Oct 18, 2019 1:45 PM

Nu.Q(TM) Vet Pre-Analytical Data to be Presented at the Veterinary Cancer Society Annual Conference in Houston, Texas

Oct 09, 2019 9:15 PM

Volition Appoints Dr. Phillip Barnes to Board of Directors

Sep 17, 2019 5:09 PM

Volition Announces Breakthrough in Enrichment of Tumor Nucleosomes

Sep 17, 2019 5:09 PM

VolitionRx Limited Announces Second Quarter 2019 Financial Results and Business Update

Aug 08, 2019 1:45 PM

Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer

Aug 07, 2019 2:00 PM

VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update

Jul 24, 2019 9:15 PM

Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock

Jul 18, 2019 2:15 PM

VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China

Jul 10, 2019 2:15 PM

VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding

May 08, 2019 10:53 AM

VolitionRx Limited Announces First Quarter 2019 Financial Results and Business Update

May 07, 2019 10:53 AM

VolitionRx Limited Executes a Contract for Clinical Trial Program in Lung Cancer

May 06, 2019 10:53 AM

VolitionRx Limited Schedules First Quarter 2019 Earnings Conference Call and Business Update

Apr 09, 2019 10:53 AM

VolitionRx Limited Hosts Capital Markets Day at the New York Stock Exchange and Issues Company Update Report

Apr 09, 2019 10:53 AM

VolitionRx Limited Signs Memorandum of Understanding with Texas A&M University for Potential Collaboration to Develop Nu.QTM Veterinary Diagnostics

Apr 04, 2019 2:00 PM

VolitionRx Limited Extends Clinical Trial Program in Lung Cancer

Mar 28, 2019 2:30 PM

VolitionRx Limited Signs Memorandum of Understanding with Fosun Long March in China

Mar 25, 2019 2:00 PM

VolitionRx Limited to Present at Conferences in March & April 2019

Mar 15, 2019 2:00 PM

VolitionRx Limited to Present at Conferences in the U.S. Next Week

Mar 13, 2019 2:30 PM

VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update

Mar 07, 2019 2:00 PM

Press Releases